What this means
Researchers plan to gather many kinds of health data from people over time. This is a registered plan, and the source does not report any findings yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site
The science
- Registered title
- Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
- Trial ID
- NCT07205510 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Sarcopenia, Metabolic Diseases, All-cause Mortality, Aging, Cardiometabolic Diseases
- What is tested
- nothing
- Sponsor
- RenJi Hospital
- Ages
- 18 Years to no maximum
- Dates
- First posted Oct 3, 2025 · updated Oct 3, 2025
Registry summary
This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
Sites (1)
- Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China., Shanghai, China